Vaxart, Inc.
VXRTFigures shown here come from public SEC filings. Dates beside each section show the available history.
How Vaxart, Inc. Makes Money
Follow each dollar of revenue through to what shareholders keep.
From revenue to net income
Pick a year or quarter. Each band's width is its dollar amount.
Source: Vaxart, Inc. — 10-K filed Feb 6, 2019
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 19 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated May 26, 2026.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Unusually large insider trades
Each trade is compared with the other insider trades of the same kind in the same security among Vaxart, Inc.'s recent filings on file. Size alone is context, not a prediction or evidence of improper trading.
- 2025-05-19 · Lo Steven: Larger than all 15 other insider purchases of Common Stock on file. SEC filing
- 2021-03-04 · Latour Wouter: Larger than 12 of the 13 other insider sales of Common Stock on file. SEC filing
- 2020-11-23 · Latour Wouter: Larger than all 13 other insider sales of Common Stock on file. SEC filing
Independent insiders buying near the same time
- 2025-11-17–2025-11-17: 4 event(s) across 2 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing , filing )
- 2025-07-25–2025-07-30: 4 event(s) across 2 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing , filing )
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2026-05-22 | Watson W. Mark · Director | Common Stock | P — Open market or private purchase | +10,000 | 0.65 | SEC filing |
| 2025-11-17 | HERON ELAINE J · Director | Common Stock | P — Open market or private purchase | +16,783 | 0.41 | SEC filing |
| 2025-11-17 | Watson W. Mark · Director | Common Stock | P — Open market or private purchase | +15,000 | 0.41 | SEC filing |
| 2025-11-17 | HERON ELAINE J · Director | Common Stock | P — Open market or private purchase | +23,217 | 0.39 | SEC filing |
| 2025-11-17 | Watson W. Mark · Director | Common Stock | P — Open market or private purchase | +5,000 | 0.41 | SEC filing |
| 2025-08-15 | Finney Kevin · Director | Common Stock | P — Open market or private purchase | +50,000 | 0.37 | SEC filing |
| 2025-08-15 | Finney Kevin · Director | Common Stock | P — Open market or private purchase | +50,000 | 0.35 | SEC filing |
| 2025-07-30 | Finney Kevin · Director | Common Stock | P — Open market or private purchase | +25,874 | 0.38 | SEC filing |
Showing 8 of 20 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2033-03-17 | Lee Phillip E · Chief Financial Officer | Stock Option (right to buy) | A — Grant, award, or other acquisition | +410,000 | SEC filing |
| 2026-05-19 | Grasman Jeroen Nicolaas · Chief Financial Officer | Common Stock | F — Payment of exercise price or tax by delivering securities | −31,395 | SEC filing |
| 2026-04-23 | BREITMEYER JAMES B · Director | Stock Option (right to buy) | A — Grant, award, or other acquisition | +157,400 | SEC filing |
| 2026-04-23 | BREITMEYER JAMES B · Director | Common Stock | A — Grant, award, or other acquisition | +78,800 | SEC filing |
| 2026-03-28 | Cummings James F. · Chief Medical Officer | Common Stock | F — Payment of exercise price or tax by delivering securities | −3,292 | SEC filing |
| 2026-03-28 | Tucker Sean · SVP, Chief Scientific Officer | Common Stock | F — Payment of exercise price or tax by delivering securities | −3,924 | SEC filing |
| 2026-03-24 | Berg Edward B · SVP, General Counsel | Common Stock | F — Payment of exercise price or tax by delivering securities | −36,418 | SEC filing |
| 2026-03-24 | Tucker Sean · SVP, Chief Scientific Officer | Common Stock | F — Payment of exercise price or tax by delivering securities | −36,418 | SEC filing |
Showing 8 of 35 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.